

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | creatine metabolic process (GO:0006600) | 7.95719987 |
| 2 | actin filament-based movement (GO:0030048) | 7.77232671 |
| 3 | regulation of relaxation of muscle (GO:1901077) | 7.38232744 |
| 4 | striated muscle contraction (GO:0006941) | 7.30285616 |
| 5 | response to muscle activity (GO:0014850) | 7.21902628 |
| 6 | skeletal muscle fiber development (GO:0048741) | 7.00145314 |
| 7 | myofibril assembly (GO:0030239) | 6.92717628 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.56059707 |
| 9 | positive regulation of protein kinase C signaling (GO:0090037) | 6.55004521 |
| 10 | sarcomere organization (GO:0045214) | 6.21895647 |
| 11 | myotube cell development (GO:0014904) | 6.18445745 |
| 12 | negative regulation of execution phase of apoptosis (GO:1900118) | 6.14708862 |
| 13 | short-term memory (GO:0007614) | 5.99538833 |
| 14 | glycogen catabolic process (GO:0005980) | 5.88142763 |
| 15 | response to inactivity (GO:0014854) | 5.85844454 |
| 16 | presynaptic membrane assembly (GO:0097105) | 5.83677941 |
| 17 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.71734551 |
| 18 | plasma membrane repair (GO:0001778) | 5.70303462 |
| 19 | skeletal muscle adaptation (GO:0043501) | 5.68885164 |
| 20 | muscle contraction (GO:0006936) | 5.68290728 |
| 21 | postsynaptic membrane organization (GO:0001941) | 5.64083194 |
| 22 | glucan catabolic process (GO:0009251) | 5.56517757 |
| 23 | cellular polysaccharide catabolic process (GO:0044247) | 5.25518314 |
| 24 | glycogen biosynthetic process (GO:0005978) | 5.14597245 |
| 25 | glucan biosynthetic process (GO:0009250) | 5.14597245 |
| 26 | cardiac muscle contraction (GO:0060048) | 5.08347813 |
| 27 | cardiac myofibril assembly (GO:0055003) | 5.07112691 |
| 28 | muscle system process (GO:0003012) | 5.06819838 |
| 29 | skeletal muscle tissue regeneration (GO:0043403) | 5.03700116 |
| 30 | NADH metabolic process (GO:0006734) | 4.99694385 |
| 31 | presynaptic membrane organization (GO:0097090) | 4.87575549 |
| 32 | positive regulation of myotube differentiation (GO:0010831) | 4.80191732 |
| 33 | muscle fiber development (GO:0048747) | 4.78309501 |
| 34 | skeletal muscle tissue development (GO:0007519) | 4.73340051 |
| 35 | actomyosin structure organization (GO:0031032) | 4.72872648 |
| 36 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.72391899 |
| 37 | polysaccharide catabolic process (GO:0000272) | 4.71758867 |
| 38 | muscle organ morphogenesis (GO:0048644) | 4.53608610 |
| 39 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 4.47989330 |
| 40 | fructose metabolic process (GO:0006000) | 4.45829587 |
| 41 | central nervous system myelination (GO:0022010) | 4.41232558 |
| 42 | axon ensheathment in central nervous system (GO:0032291) | 4.41232558 |
| 43 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.38748748 |
| 44 | spermatid nucleus differentiation (GO:0007289) | 4.33111187 |
| 45 | 2-oxoglutarate metabolic process (GO:0006103) | 4.30945894 |
| 46 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.26584525 |
| 47 | protein heterotetramerization (GO:0051290) | 4.24733508 |
| 48 | regulation of actin filament-based movement (GO:1903115) | 4.24297157 |
| 49 | striated muscle adaptation (GO:0014888) | 4.23950974 |
| 50 | metanephric nephron tubule development (GO:0072234) | 4.16499758 |
| 51 | metanephric tubule development (GO:0072170) | 4.16499758 |
| 52 | glycogen metabolic process (GO:0005977) | 4.15241152 |
| 53 | muscle cell fate commitment (GO:0042693) | 4.14148819 |
| 54 | muscle cell cellular homeostasis (GO:0046716) | 4.14114515 |
| 55 | response to activity (GO:0014823) | 4.12774929 |
| 56 | IMP metabolic process (GO:0046040) | 4.10316737 |
| 57 | glucan metabolic process (GO:0044042) | 4.08108260 |
| 58 | cellular glucan metabolic process (GO:0006073) | 4.08108260 |
| 59 | cardiac muscle hypertrophy (GO:0003300) | 4.07341433 |
| 60 | gluconeogenesis (GO:0006094) | 4.05960885 |
| 61 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.04236165 |
| 62 | GMP metabolic process (GO:0046037) | 4.02097563 |
| 63 | interkinetic nuclear migration (GO:0022027) | 3.98754461 |
| 64 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.96835704 |
| 65 | metanephric nephron epithelium development (GO:0072243) | 3.91298190 |
| 66 | regulation of cell communication by electrical coupling (GO:0010649) | 3.89962329 |
| 67 | endothelium development (GO:0003158) | 3.89368174 |
| 68 | striated muscle hypertrophy (GO:0014897) | 3.89185683 |
| 69 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.88856503 |
| 70 | melanin metabolic process (GO:0006582) | 3.80608418 |
| 71 | metanephric epithelium development (GO:0072207) | 3.75395098 |
| 72 | neuronal action potential propagation (GO:0019227) | 3.73914923 |
| 73 | muscle tissue morphogenesis (GO:0060415) | 3.73172442 |
| 74 | cranial nerve morphogenesis (GO:0021602) | 3.72276199 |
| 75 | negative regulation of necroptotic process (GO:0060546) | 3.70506232 |
| 76 | regulation of pigment cell differentiation (GO:0050932) | 3.70295980 |
| 77 | limb bud formation (GO:0060174) | 3.67723129 |
| 78 | organ growth (GO:0035265) | 3.67365631 |
| 79 | facial nerve structural organization (GO:0021612) | 3.65692124 |
| 80 | hexose biosynthetic process (GO:0019319) | 3.65586536 |
| 81 | muscle adaptation (GO:0043500) | 3.63839175 |
| 82 | negative regulation of muscle contraction (GO:0045932) | 3.63581275 |
| 83 | tricarboxylic acid cycle (GO:0006099) | 3.62977616 |
| 84 | nephron epithelium development (GO:0072009) | 3.61029535 |
| 85 | striated muscle cell development (GO:0055002) | 3.60853541 |
| 86 | muscle hypertrophy (GO:0014896) | 3.60413493 |
| 87 | * muscle organ development (GO:0007517) | 3.57595717 |
| 88 | * muscle structure development (GO:0061061) | 3.56709088 |
| 89 | viral transcription (GO:0019083) | 3.54898584 |
| 90 | regulation of striated muscle contraction (GO:0006942) | 3.54526934 |
| 91 | melanin biosynthetic process (GO:0042438) | 3.52591363 |
| 92 | purine nucleotide salvage (GO:0032261) | 3.51506389 |
| 93 | ribosomal small subunit biogenesis (GO:0042274) | 3.51434624 |
| 94 | regulation of protein kinase C signaling (GO:0090036) | 3.49302654 |
| 95 | striated muscle atrophy (GO:0014891) | 3.46862269 |
| 96 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.45165818 |
| 97 | GTP biosynthetic process (GO:0006183) | 3.43083174 |
| 98 | myoblast fusion (GO:0007520) | 3.41068907 |
| 99 | retina layer formation (GO:0010842) | 3.38238207 |
| 100 | AMP metabolic process (GO:0046033) | 3.37629456 |
| 101 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.36707191 |
| 102 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.36707191 |
| 103 | regulation of myoblast differentiation (GO:0045661) | 3.36020751 |
| 104 | oxaloacetate metabolic process (GO:0006107) | 3.33554670 |
| 105 | ubiquinone biosynthetic process (GO:0006744) | 3.30122097 |
| 106 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.28824972 |
| 107 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.28270748 |
| 108 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.28270748 |
| 109 | monosaccharide biosynthetic process (GO:0046364) | 3.27303813 |
| 110 | regulation of myotube differentiation (GO:0010830) | 3.25510707 |
| 111 | regulation of protein kinase A signaling (GO:0010738) | 3.24170930 |
| 112 | mesonephros development (GO:0001823) | 3.23753165 |
| 113 | translational termination (GO:0006415) | 3.20167812 |
| 114 | muscle cell development (GO:0055001) | 3.16464178 |
| 115 | cellular carbohydrate catabolic process (GO:0044275) | 3.16208772 |
| 116 | succinate metabolic process (GO:0006105) | 3.14670514 |
| 117 | eyelid development in camera-type eye (GO:0061029) | 3.14389776 |
| 118 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.14177453 |
| 119 | adult heart development (GO:0007512) | 3.12857320 |
| 120 | striated muscle tissue development (GO:0014706) | 3.12739761 |
| 121 | regulation of sequestering of triglyceride (GO:0010889) | 3.11528375 |
| 122 | cardiac muscle adaptation (GO:0014887) | 3.09823047 |
| 123 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.09823047 |
| 124 | muscle hypertrophy in response to stress (GO:0003299) | 3.09823047 |
| 125 | cellular polysaccharide biosynthetic process (GO:0033692) | 3.09146600 |
| 126 | muscle atrophy (GO:0014889) | 3.08701607 |
| 127 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.08525283 |
| 128 | heart process (GO:0003015) | 3.08270737 |
| 129 | heart contraction (GO:0060047) | 3.08270737 |
| 130 | regulation of timing of cell differentiation (GO:0048505) | 3.07473067 |
| 131 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.06749272 |
| 132 | lymphoid progenitor cell differentiation (GO:0002320) | 3.05871950 |
| 133 | cranial nerve structural organization (GO:0021604) | 3.02760604 |
| 134 | import into cell (GO:0098657) | 3.01701074 |
| 135 | regulation of development, heterochronic (GO:0040034) | 3.01166509 |
| 136 | response to folic acid (GO:0051593) | 3.01034996 |
| 137 | branch elongation of an epithelium (GO:0060602) | 3.00044183 |
| 138 | positive regulation of steroid hormone secretion (GO:2000833) | 2.97601260 |
| 139 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.97453476 |
| 140 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.97453476 |
| 141 | secondary metabolite biosynthetic process (GO:0044550) | 2.94824479 |
| 142 | regulation of fibroblast growth factor receptor signaling pathway (GO:0040036) | 2.93660853 |
| 143 | omega-hydroxylase P450 pathway (GO:0097267) | 2.85222953 |
| 144 | positive regulation of calcium ion import (GO:0090280) | 2.83069359 |
| 145 | DNA methylation involved in gamete generation (GO:0043046) | 2.81685626 |
| 146 | mature B cell differentiation (GO:0002335) | 2.80991454 |
| 147 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.79791847 |
| 148 | cotranslational protein targeting to membrane (GO:0006613) | 2.79488051 |
| 149 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.79043447 |
| 150 | protein targeting to ER (GO:0045047) | 2.78758696 |
| 151 | pattern specification involved in kidney development (GO:0061004) | 2.78594577 |
| 152 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.75554417 |
| 153 | cornea development in camera-type eye (GO:0061303) | 2.74036599 |
| 154 | UTP biosynthetic process (GO:0006228) | 2.72947732 |
| 155 | nephron tubule development (GO:0072080) | 2.72625943 |
| 156 | UV protection (GO:0009650) | 2.70272859 |
| 157 | membrane assembly (GO:0071709) | 2.67246183 |
| 158 | endocrine hormone secretion (GO:0060986) | 2.65898178 |
| 159 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.65759721 |
| 160 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.63880803 |
| 161 | otic vesicle formation (GO:0030916) | 2.63697294 |
| 162 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.62971311 |
| 163 | negative regulation of Ras GTPase activity (GO:0034261) | 2.58619887 |
| 164 | thyroid gland development (GO:0030878) | 2.57344914 |
| 165 | cell proliferation in forebrain (GO:0021846) | 2.57334419 |
| 166 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.57009945 |
| 167 | forebrain neuron differentiation (GO:0021879) | 2.56684399 |
| 168 | superoxide anion generation (GO:0042554) | 2.55910367 |
| 169 | cilium movement (GO:0003341) | 2.54493858 |
| 170 | protein localization to endoplasmic reticulum (GO:0070972) | 2.54235802 |
| 171 | sympathetic nervous system development (GO:0048485) | 2.52042181 |
| 172 | keratinocyte development (GO:0003334) | 2.51943083 |
| 173 | developmental pigmentation (GO:0048066) | 2.45609456 |
| 174 | regulation of execution phase of apoptosis (GO:1900117) | 2.43939620 |
| 175 | proteasome assembly (GO:0043248) | 2.43773442 |
| 176 | renal tubule development (GO:0061326) | 2.41949200 |
| 177 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.38793506 |
| 178 | amino sugar catabolic process (GO:0046348) | 2.38344325 |
| 179 | response to peptidoglycan (GO:0032494) | 2.37980896 |
| 180 | forebrain neuron development (GO:0021884) | 2.36963162 |
| 181 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.36944544 |
| 182 | centriole replication (GO:0007099) | 2.35472960 |
| 183 | neuron cell-cell adhesion (GO:0007158) | 2.35127663 |
| 184 | viral genome replication (GO:0019079) | 2.32563056 |
| 185 | generation of neurons (GO:0048699) | 2.32442993 |
| 186 | DNA ligation (GO:0006266) | 2.32138131 |
| 187 | mesenchymal to epithelial transition (GO:0060231) | 2.31438670 |
| 188 | spinal cord motor neuron differentiation (GO:0021522) | 2.29957467 |
| 189 | nephron tubule formation (GO:0072079) | 2.28271777 |
| 190 | Leydig cell differentiation (GO:0033327) | 2.28220524 |
| 191 | righting reflex (GO:0060013) | 2.28027489 |
| 192 | oligodendrocyte differentiation (GO:0048709) | 2.26818472 |
| 193 | RNA destabilization (GO:0050779) | 2.25938489 |
| 194 | muscle filament sliding (GO:0030049) | 12.8371930 |
| 195 | actin-myosin filament sliding (GO:0033275) | 12.8371930 |
| 196 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 11.5751175 |
| 197 | skeletal muscle contraction (GO:0003009) | 10.6444174 |
| 198 | actin-mediated cell contraction (GO:0070252) | 10.4415233 |
| 199 | regulation of skeletal muscle contraction (GO:0014819) | 10.1491943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.67096594 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.77961750 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.16255122 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.06721409 |
| 5 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.99852435 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.92710697 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.81096660 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.80038321 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.76557413 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.73853165 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.68060874 |
| 12 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.64484651 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.62137258 |
| 14 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.59611747 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.57150021 |
| 16 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.54449199 |
| 17 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.45561473 |
| 18 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.42269544 |
| 19 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.42269544 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.30510561 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.26734270 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.26734270 |
| 23 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.25510745 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.24336861 |
| 25 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.22236695 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.20949882 |
| 27 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.20493795 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.19957032 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 2.17992897 |
| 30 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.17297876 |
| 31 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.14790445 |
| 32 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.14358258 |
| 33 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.12596716 |
| 34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.09951608 |
| 35 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.06342761 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.05903657 |
| 37 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.02872976 |
| 38 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.00276352 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.99831293 |
| 40 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.99133086 |
| 41 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.97585549 |
| 42 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.92220051 |
| 43 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.91863180 |
| 44 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.86677621 |
| 45 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.84757845 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.82419330 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.82396049 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.78720815 |
| 49 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.76248408 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.74134627 |
| 51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72992886 |
| 52 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.72610264 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.71974006 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.70887758 |
| 55 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.70104319 |
| 56 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.68302955 |
| 57 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.68177544 |
| 58 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.67797383 |
| 59 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.67538729 |
| 60 | * MAF_26560356_Chip-Seq_TH1_Human | 1.66791645 |
| 61 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.63644410 |
| 62 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.63644410 |
| 63 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.63644410 |
| 64 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.63210625 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.61991384 |
| 66 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.61548094 |
| 67 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.61307327 |
| 68 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.61132739 |
| 69 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.58463636 |
| 70 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.57689616 |
| 71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56738342 |
| 72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55261695 |
| 73 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.51875673 |
| 74 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.51033784 |
| 75 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50621775 |
| 76 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.50614658 |
| 77 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.48465120 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.47992841 |
| 79 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.47325106 |
| 80 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47260165 |
| 81 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.47060057 |
| 82 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47000016 |
| 83 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.46274882 |
| 84 | MYC_22102868_ChIP-Seq_BL_Human | 1.45711260 |
| 85 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.45014894 |
| 86 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.44197692 |
| 87 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.44074027 |
| 88 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.43570733 |
| 89 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.43236655 |
| 90 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.42183494 |
| 91 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.41313722 |
| 92 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41125900 |
| 93 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.41002928 |
| 94 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40799825 |
| 95 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.40395329 |
| 96 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.39230578 |
| 97 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.38521479 |
| 98 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37274973 |
| 99 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37067394 |
| 100 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35745860 |
| 101 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.34692065 |
| 102 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.33185048 |
| 103 | MAF_26560356_Chip-Seq_TH2_Human | 1.32732287 |
| 104 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.32345333 |
| 105 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.31045268 |
| 106 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.29777514 |
| 107 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.29248355 |
| 108 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.29200196 |
| 109 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.28900096 |
| 110 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27785612 |
| 111 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26879763 |
| 112 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.26786642 |
| 113 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26401774 |
| 114 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.26046407 |
| 115 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.25816532 |
| 116 | P68_20966046_ChIP-Seq_HELA_Human | 1.25757713 |
| 117 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25421937 |
| 118 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.24777952 |
| 119 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.24369638 |
| 120 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.23916707 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23488024 |
| 122 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.23453660 |
| 123 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23350351 |
| 124 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.22952734 |
| 125 | P300_19829295_ChIP-Seq_ESCs_Human | 1.21329995 |
| 126 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.21197483 |
| 127 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.20691374 |
| 128 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19859267 |
| 129 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19093116 |
| 130 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19032660 |
| 131 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.18786527 |
| 132 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18213710 |
| 133 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.17942629 |
| 134 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.17865850 |
| 135 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17735393 |
| 136 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.17481327 |
| 137 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17175839 |
| 138 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16634159 |
| 139 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.16614452 |
| 140 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15960611 |
| 141 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.15781781 |
| 142 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.15593765 |
| 143 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.15462892 |
| 144 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.15208540 |
| 145 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15110653 |
| 146 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.12285256 |
| 147 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.12269019 |
| 148 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.12263100 |
| 149 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12218897 |
| 150 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11940769 |
| 151 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11819173 |
| 152 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11729391 |
| 153 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.11510596 |
| 154 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.10643260 |
| 155 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.10509443 |
| 156 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.10367363 |
| 157 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.10227232 |
| 158 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10082644 |
| 159 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09857061 |
| 160 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09528023 |
| 161 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08749890 |
| 162 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07792503 |
| 163 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.07253447 |
| 164 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06148989 |
| 165 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04944710 |
| 166 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03368292 |
| 167 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.03331493 |
| 168 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02859439 |
| 169 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.02704137 |
| 170 | FUS_26573619_Chip-Seq_HEK293_Human | 1.01763857 |
| 171 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01428855 |
| 172 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01332723 |
| 173 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.00680986 |
| 174 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.99433359 |
| 175 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99118643 |
| 176 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98365875 |
| 177 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97937093 |
| 178 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97528228 |
| 179 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97307622 |
| 180 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.97139357 |
| 181 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96741436 |
| 182 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96081666 |
| 183 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.95978303 |
| 184 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94961534 |
| 185 | KDM2B_26808549_Chip-Seq_REH_Human | 0.94948046 |
| 186 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.94006472 |
| 187 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.93931240 |
| 188 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.93585260 |
| 189 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93092240 |
| 190 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93079585 |
| 191 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91326240 |
| 192 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90277756 |
| 193 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.90217193 |
| 194 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88685722 |
| 195 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.88486828 |
| 196 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.88179627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 7.94132856 |
| 2 | MP0003646_muscle_fatigue | 6.90113543 |
| 3 | MP0005409_darkened_coat_color | 5.80989006 |
| 4 | MP0000749_muscle_degeneration | 5.61101144 |
| 5 | MP0001188_hyperpigmentation | 5.31839380 |
| 6 | MP0004381_abnormal_hair_follicle | 4.82309450 |
| 7 | MP0009379_abnormal_foot_pigmentation | 4.30154468 |
| 8 | MP0004036_abnormal_muscle_relaxation | 4.18022954 |
| 9 | MP0005451_abnormal_body_composition | 4.08140779 |
| 10 | MP0002106_abnormal_muscle_physiology | 3.77347643 |
| 11 | MP0000747_muscle_weakness | 3.60554682 |
| 12 | MP0000759_abnormal_skeletal_muscle | 3.59320850 |
| 13 | MP0004087_abnormal_muscle_fiber | 3.33828715 |
| 14 | MP0005174_abnormal_tail_pigmentation | 3.32187677 |
| 15 | MP0006292_abnormal_olfactory_placode | 3.31643336 |
| 16 | MP0004233_abnormal_muscle_weight | 3.27656503 |
| 17 | MP0002332_abnormal_exercise_endurance | 3.27124637 |
| 18 | MP0005369_muscle_phenotype | 3.16973006 |
| 19 | MP0002269_muscular_atrophy | 2.97750218 |
| 20 | MP0000015_abnormal_ear_pigmentation | 2.86547676 |
| 21 | MP0004130_abnormal_muscle_cell | 2.75748981 |
| 22 | MP0004084_abnormal_cardiac_muscle | 2.73600941 |
| 23 | MP0002102_abnormal_ear_morphology | 2.68749927 |
| 24 | MP0005620_abnormal_muscle_contractility | 2.66305108 |
| 25 | MP0003724_increased_susceptibility_to | 2.62825714 |
| 26 | MP0005330_cardiomyopathy | 2.56946398 |
| 27 | MP0003880_abnormal_central_pattern | 2.50392761 |
| 28 | MP0003315_abnormal_perineum_morphology | 2.30174748 |
| 29 | MP0000733_abnormal_muscle_development | 2.23417524 |
| 30 | MP0006036_abnormal_mitochondrial_physio | 2.06278889 |
| 31 | MP0002972_abnormal_cardiac_muscle | 2.01880312 |
| 32 | MP0002177_abnormal_outer_ear | 1.95642739 |
| 33 | MP0004742_abnormal_vestibular_system | 1.91647374 |
| 34 | MP0003303_peritoneal_inflammation | 1.89423242 |
| 35 | MP0002108_abnormal_muscle_morphology | 1.87952809 |
| 36 | MP0002277_abnormal_respiratory_mucosa | 1.74330098 |
| 37 | MP0003938_abnormal_ear_development | 1.72584372 |
| 38 | MP0004510_myositis | 1.70905808 |
| 39 | MP0004145_abnormal_muscle_electrophysio | 1.58736327 |
| 40 | MP0002249_abnormal_larynx_morphology | 1.57070626 |
| 41 | MP0002837_dystrophic_cardiac_calcinosis | 1.56525346 |
| 42 | MP0000566_synostosis | 1.55392213 |
| 43 | MP0000049_abnormal_middle_ear | 1.53079483 |
| 44 | MP0010630_abnormal_cardiac_muscle | 1.51926764 |
| 45 | MP0009250_abnormal_appendicular_skeleto | 1.50282478 |
| 46 | MP0008260_abnormal_autophagy | 1.47708947 |
| 47 | MP0004484_altered_response_of | 1.46762891 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.40997957 |
| 49 | MP0005266_abnormal_metabolism | 1.39280051 |
| 50 | MP0002127_abnormal_cardiovascular_syste | 1.35003742 |
| 51 | MP0000579_abnormal_nail_morphology | 1.34155257 |
| 52 | MP0004185_abnormal_adipocyte_glucose | 1.33790288 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.32848960 |
| 54 | MP0000751_myopathy | 1.31579270 |
| 55 | MP0005385_cardiovascular_system_phenoty | 1.30350631 |
| 56 | MP0001544_abnormal_cardiovascular_syste | 1.30350631 |
| 57 | MP0006138_congestive_heart_failure | 1.30021544 |
| 58 | MP0002095_abnormal_skin_pigmentation | 1.28627337 |
| 59 | MP0003221_abnormal_cardiomyocyte_apopto | 1.25660442 |
| 60 | MP0001986_abnormal_taste_sensitivity | 1.22432497 |
| 61 | MP0004215_abnormal_myocardial_fiber | 1.21532307 |
| 62 | MP0003937_abnormal_limbs/digits/tail_de | 1.20057429 |
| 63 | MP0001968_abnormal_touch/_nociception | 1.11391990 |
| 64 | MP0000026_abnormal_inner_ear | 1.11327993 |
| 65 | MP0008995_early_reproductive_senescence | 1.09453524 |
| 66 | MP0002971_abnormal_brown_adipose | 1.09262930 |
| 67 | MP0003436_decreased_susceptibility_to | 1.08416563 |
| 68 | MP0005171_absent_coat_pigmentation | 1.07438715 |
| 69 | MP0000467_abnormal_esophagus_morphology | 1.04843997 |
| 70 | MP0001346_abnormal_lacrimal_gland | 1.04747822 |
| 71 | MP0002933_joint_inflammation | 1.00755989 |
| 72 | MP0005666_abnormal_adipose_tissue | 1.00112712 |
| 73 | MP0003828_pulmonary_edema | 0.99810294 |
| 74 | MP0002282_abnormal_trachea_morphology | 0.97691837 |
| 75 | MP0004142_abnormal_muscle_tone | 0.96603218 |
| 76 | MP0002751_abnormal_autonomic_nervous | 0.96276774 |
| 77 | MP0005375_adipose_tissue_phenotype | 0.95576567 |
| 78 | MP0002638_abnormal_pupillary_reflex | 0.94961688 |
| 79 | MP0001661_extended_life_span | 0.94712813 |
| 80 | MP0003950_abnormal_plasma_membrane | 0.94672237 |
| 81 | MP0000750_abnormal_muscle_regeneration | 0.94647206 |
| 82 | MP0002148_abnormal_hypersensitivity_rea | 0.94285022 |
| 83 | MP0001340_abnormal_eyelid_morphology | 0.92064077 |
| 84 | MP0005000_abnormal_immune_tolerance | 0.91601225 |
| 85 | MP0004270_analgesia | 0.85168169 |
| 86 | MP0006276_abnormal_autonomic_nervous | 0.84719626 |
| 87 | MP0002098_abnormal_vibrissa_morphology | 0.83498502 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.82436712 |
| 89 | MP0003385_abnormal_body_wall | 0.81160845 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 0.80967294 |
| 91 | MP0001486_abnormal_startle_reflex | 0.80561958 |
| 92 | MP0000920_abnormal_myelination | 0.80078328 |
| 93 | MP0003718_maternal_effect | 0.79761903 |
| 94 | MP0005595_abnormal_vascular_smooth | 0.77769452 |
| 95 | MP0003011_delayed_dark_adaptation | 0.76056111 |
| 96 | MP0003705_abnormal_hypodermis_morpholog | 0.75924201 |
| 97 | MP0003941_abnormal_skin_development | 0.75769111 |
| 98 | MP0000631_abnormal_neuroendocrine_gland | 0.75217623 |
| 99 | MP0000613_abnormal_salivary_gland | 0.74701494 |
| 100 | MP0000003_abnormal_adipose_tissue | 0.74088888 |
| 101 | MP0002067_abnormal_sensory_capabilities | 0.73498183 |
| 102 | MP0003755_abnormal_palate_morphology | 0.72039657 |
| 103 | MP0000372_irregular_coat_pigmentation | 0.71262325 |
| 104 | MP0005670_abnormal_white_adipose | 0.70757503 |
| 105 | MP0000762_abnormal_tongue_morphology | 0.70249756 |
| 106 | MP0009785_altered_susceptibility_to | 0.69802860 |
| 107 | MP0001851_eye_inflammation | 0.68982550 |
| 108 | MP0001663_abnormal_digestive_system | 0.68822740 |
| 109 | MP0005423_abnormal_somatic_nervous | 0.68304719 |
| 110 | MP0005166_decreased_susceptibility_to | 0.66604071 |
| 111 | MP0010030_abnormal_orbit_morphology | 0.65234269 |
| 112 | MP0003806_abnormal_nucleotide_metabolis | 0.65139144 |
| 113 | MP0000681_abnormal_thyroid_gland | 0.64964630 |
| 114 | MP0002752_abnormal_somatic_nervous | 0.64805558 |
| 115 | MP0005083_abnormal_biliary_tract | 0.64008386 |
| 116 | MP0002419_abnormal_innate_immunity | 0.62796302 |
| 117 | MP0001963_abnormal_hearing_physiology | 0.62689312 |
| 118 | MP0001919_abnormal_reproductive_system | 0.62299690 |
| 119 | MP0008775_abnormal_heart_ventricle | 0.61993720 |
| 120 | MP0003045_fibrosis | 0.61703082 |
| 121 | MP0000266_abnormal_heart_morphology | 0.61457899 |
| 122 | MP0009764_decreased_sensitivity_to | 0.60836210 |
| 123 | MP0005381_digestive/alimentary_phenotyp | 0.60632316 |
| 124 | MP0009840_abnormal_foam_cell | 0.60142476 |
| 125 | MP0000858_altered_metastatic_potential | 0.59899989 |
| 126 | MP0002938_white_spotting | 0.59645139 |
| 127 | MP0001853_heart_inflammation | 0.59380220 |
| 128 | MP0000432_abnormal_head_morphology | 0.59329077 |
| 129 | MP0005025_abnormal_response_to | 0.59318137 |
| 130 | MP0001533_abnormal_skeleton_physiology | 0.59239161 |
| 131 | MP0004147_increased_porphyrin_level | 0.59225789 |
| 132 | MP0003137_abnormal_impulse_conducting | 0.59043413 |
| 133 | MP0005075_abnormal_melanosome_morpholog | 0.58672868 |
| 134 | MP0000383_abnormal_hair_follicle | 0.58348001 |
| 135 | MP0001970_abnormal_pain_threshold | 0.58020781 |
| 136 | MP0002160_abnormal_reproductive_system | 0.57615552 |
| 137 | MP0005164_abnormal_response_to | 0.57394312 |
| 138 | MP0005167_abnormal_blood-brain_barrier | 0.57287055 |
| 139 | MP0005084_abnormal_gallbladder_morpholo | 0.56043096 |
| 140 | MP0005165_increased_susceptibility_to | 0.55909944 |
| 141 | MP0000343_altered_response_to | 0.55609473 |
| 142 | MP0002272_abnormal_nervous_system | 0.55450662 |
| 143 | MP0000647_abnormal_sebaceous_gland | 0.53330837 |
| 144 | MP0005671_abnormal_response_to | 0.53061674 |
| 145 | MP0002557_abnormal_social/conspecific_i | 0.52997760 |
| 146 | MP0002723_abnormal_immune_serum | 0.52908063 |
| 147 | MP0001286_abnormal_eye_development | 0.52591890 |
| 148 | MP0000778_abnormal_nervous_system | 0.52091782 |
| 149 | MP0003935_abnormal_craniofacial_develop | 0.51996542 |
| 150 | MP0009333_abnormal_splenocyte_physiolog | 0.51591214 |
| 151 | MP0003448_altered_tumor_morphology | 0.51585722 |
| 152 | MP0002998_abnormal_bone_remodeling | 0.51180180 |
| 153 | MP0004134_abnormal_chest_morphology | 0.50588312 |
| 154 | MP0001664_abnormal_digestion | 0.50292314 |
| 155 | MP0005197_abnormal_uvea_morphology | 0.50253659 |
| 156 | MP0002116_abnormal_craniofacial_bone | 0.50185004 |
| 157 | MP0005376_homeostasis/metabolism_phenot | 0.47227877 |
| 158 | MP0002822_catalepsy | 0.46690150 |
| 159 | MP0005058_abnormal_lysosome_morphology | 0.46442632 |
| 160 | MP0003191_abnormal_cellular_cholesterol | 0.45514058 |
| 161 | MP0004858_abnormal_nervous_system | 0.44114147 |
| 162 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.43657550 |
| 163 | MP0005319_abnormal_enzyme/_coenzyme | 0.43508323 |
| 164 | MP0002128_abnormal_blood_circulation | 0.42894363 |
| 165 | MP0004085_abnormal_heartbeat | 0.42306580 |
| 166 | MP0003279_aneurysm | 0.41446107 |
| 167 | MP0002078_abnormal_glucose_homeostasis | 0.41429702 |
| 168 | MP0003879_abnormal_hair_cell | 0.41009800 |
| 169 | MP0009278_abnormal_bone_marrow | 0.39367248 |
| 170 | MP0005464_abnormal_platelet_physiology | 0.38030412 |
| 171 | MP0005535_abnormal_body_temperature | 0.37516050 |
| 172 | MP0006035_abnormal_mitochondrial_morpho | 0.37030827 |
| 173 | MP0003075_altered_response_to | 0.35555903 |
| 174 | MP0002896_abnormal_bone_mineralization | 0.33982619 |
| 175 | MP0001299_abnormal_eye_distance/ | 0.33328118 |
| 176 | MP0002132_abnormal_respiratory_system | 0.32979453 |
| 177 | MP0002114_abnormal_axial_skeleton | 0.32610350 |
| 178 | MP0009672_abnormal_birth_weight | 0.32357808 |
| 179 | MP0005334_abnormal_fat_pad | 0.29921652 |
| 180 | MP0003948_abnormal_gas_homeostasis | 0.29430977 |
| 181 | MP0000678_abnormal_parathyroid_gland | 0.28851992 |
| 182 | MP0005452_abnormal_adipose_tissue | 0.28089001 |
| 183 | MP0008438_abnormal_cutaneous_collagen | 0.27904145 |
| 184 | MP0008874_decreased_physiological_sensi | 0.26196825 |
| 185 | MP0000249_abnormal_blood_vessel | 0.26158630 |
| 186 | MP0003959_abnormal_lean_body | 0.24426143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 8.50415100 |
| 2 | Exercise-induced myalgia (HP:0003738) | 8.30758672 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 7.47943707 |
| 4 | Myopathic facies (HP:0002058) | 6.16156566 |
| 5 | Distal arthrogryposis (HP:0005684) | 6.08246963 |
| 6 | EMG: myopathic abnormalities (HP:0003458) | 5.23237662 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 5.23132925 |
| 8 | Rhabdomyolysis (HP:0003201) | 5.04015493 |
| 9 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.95690324 |
| 10 | Ulnar deviation of the wrist (HP:0003049) | 4.92883440 |
| 11 | Myoglobinuria (HP:0002913) | 4.80692313 |
| 12 | Muscle fiber splitting (HP:0003555) | 4.77326718 |
| 13 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.67075273 |
| 14 | Hyporeflexia of lower limbs (HP:0002600) | 4.42217808 |
| 15 | Sex reversal (HP:0012245) | 4.39278789 |
| 16 | Abnormal sex determination (HP:0012244) | 4.39278789 |
| 17 | Neck muscle weakness (HP:0000467) | 4.37266878 |
| 18 | Calcaneovalgus deformity (HP:0001848) | 4.31605467 |
| 19 | Abnormality of the calf musculature (HP:0001430) | 4.22861382 |
| 20 | Increased connective tissue (HP:0009025) | 4.12693085 |
| 21 | Subaortic stenosis (HP:0001682) | 4.07126071 |
| 22 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.07126071 |
| 23 | Abnormality of secondary sexual hair (HP:0009888) | 4.05675900 |
| 24 | Abnormality of the axillary hair (HP:0100134) | 4.05675900 |
| 25 | Rimmed vacuoles (HP:0003805) | 4.02079735 |
| 26 | Muscle stiffness (HP:0003552) | 4.01519051 |
| 27 | Difficulty running (HP:0009046) | 3.91787386 |
| 28 | Obstructive sleep apnea (HP:0002870) | 3.84172509 |
| 29 | Deformed tarsal bones (HP:0008119) | 3.83821367 |
| 30 | Increased variability in muscle fiber diameter (HP:0003557) | 3.81752770 |
| 31 | Distal lower limb muscle weakness (HP:0009053) | 3.72579343 |
| 32 | Abnormal ciliary motility (HP:0012262) | 3.70896371 |
| 33 | Absent phalangeal crease (HP:0006109) | 3.57633283 |
| 34 | Asymmetric septal hypertrophy (HP:0001670) | 3.54624489 |
| 35 | Septo-optic dysplasia (HP:0100842) | 3.52552774 |
| 36 | Thyroid-stimulating hormone excess (HP:0002925) | 3.52012442 |
| 37 | Absent/shortened dynein arms (HP:0200106) | 3.47776208 |
| 38 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.47776208 |
| 39 | Split foot (HP:0001839) | 3.38064622 |
| 40 | Attenuation of retinal blood vessels (HP:0007843) | 3.37535489 |
| 41 | Myotonia (HP:0002486) | 3.31912204 |
| 42 | Parakeratosis (HP:0001036) | 3.30777603 |
| 43 | Malignant hyperthermia (HP:0002047) | 3.28968235 |
| 44 | Frequent falls (HP:0002359) | 3.27157639 |
| 45 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.26933248 |
| 46 | Joint hemorrhage (HP:0005261) | 3.20904520 |
| 47 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.19165675 |
| 48 | Areflexia of lower limbs (HP:0002522) | 3.18973839 |
| 49 | Absent septum pellucidum (HP:0001331) | 3.09257767 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 3.07272380 |
| 51 | Obstructive lung disease (HP:0006536) | 3.07272380 |
| 52 | Optic nerve hypoplasia (HP:0000609) | 2.98264744 |
| 53 | Abnormal finger flexion creases (HP:0006143) | 2.96288663 |
| 54 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.94948706 |
| 55 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.94948706 |
| 56 | Nonprogressive disorder (HP:0003680) | 2.94721564 |
| 57 | Abnormality of the septum pellucidum (HP:0007375) | 2.94566853 |
| 58 | Sudden death (HP:0001699) | 2.93261124 |
| 59 | Slender build (HP:0001533) | 2.92428888 |
| 60 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.89007738 |
| 61 | Agammaglobulinemia (HP:0004432) | 2.85241534 |
| 62 | EMG: neuropathic changes (HP:0003445) | 2.83174647 |
| 63 | Generalized muscle weakness (HP:0003324) | 2.82466171 |
| 64 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.80891896 |
| 65 | Bulbar palsy (HP:0001283) | 2.76351648 |
| 66 | Concave nail (HP:0001598) | 2.73487823 |
| 67 | Distal lower limb amyotrophy (HP:0008944) | 2.71591168 |
| 68 | Abnormality of the calcaneus (HP:0008364) | 2.58508419 |
| 69 | Progressive muscle weakness (HP:0003323) | 2.57756230 |
| 70 | Spinal rigidity (HP:0003306) | 2.56212385 |
| 71 | Stomatitis (HP:0010280) | 2.53241347 |
| 72 | Short tibia (HP:0005736) | 2.52396691 |
| 73 | Weak cry (HP:0001612) | 2.51155984 |
| 74 | Optic disc pallor (HP:0000543) | 2.50226884 |
| 75 | Menorrhagia (HP:0000132) | 2.47767672 |
| 76 | Bundle branch block (HP:0011710) | 2.47608295 |
| 77 | Muscle fiber inclusion bodies (HP:0100299) | 2.44831966 |
| 78 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.44262288 |
| 79 | Aplasia cutis congenita (HP:0001057) | 2.42787694 |
| 80 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.39368344 |
| 81 | Prolonged partial thromboplastin time (HP:0003645) | 2.37774271 |
| 82 | Supernumerary spleens (HP:0009799) | 2.35486365 |
| 83 | Scapular winging (HP:0003691) | 2.35481024 |
| 84 | Laryngomalacia (HP:0001601) | 2.34275281 |
| 85 | Reticulocytopenia (HP:0001896) | 2.33630397 |
| 86 | Limb-girdle muscle atrophy (HP:0003797) | 2.32921959 |
| 87 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.32784205 |
| 88 | Dilated cardiomyopathy (HP:0001644) | 2.32127580 |
| 89 | Nemaline bodies (HP:0003798) | 2.29207124 |
| 90 | Ventricular tachycardia (HP:0004756) | 2.28135244 |
| 91 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.27689980 |
| 92 | Gowers sign (HP:0003391) | 2.26829594 |
| 93 | Fetal akinesia sequence (HP:0001989) | 2.25928200 |
| 94 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.23969669 |
| 95 | Difficulty climbing stairs (HP:0003551) | 2.21516407 |
| 96 | Fatigable weakness (HP:0003473) | 2.21509075 |
| 97 | Abnormality of the neuromuscular junction (HP:0003398) | 2.21509075 |
| 98 | Overfolded helix (HP:0000396) | 2.21406538 |
| 99 | Type I transferrin isoform profile (HP:0003642) | 2.20802663 |
| 100 | Ragged-red muscle fibers (HP:0003200) | 2.16052982 |
| 101 | Patchy hypopigmentation of hair (HP:0011365) | 2.15465698 |
| 102 | Sleep apnea (HP:0010535) | 2.14391607 |
| 103 | Conical tooth (HP:0000698) | 2.14360626 |
| 104 | Waddling gait (HP:0002515) | 2.11995778 |
| 105 | Macrocytic anemia (HP:0001972) | 2.11671838 |
| 106 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.11222177 |
| 107 | White forelock (HP:0002211) | 2.11021715 |
| 108 | Hip contracture (HP:0003273) | 2.09788314 |
| 109 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.07374100 |
| 110 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.07360267 |
| 111 | Decreased central vision (HP:0007663) | 2.06927385 |
| 112 | Atelectasis (HP:0100750) | 2.06692816 |
| 113 | Hypoplasia of the radius (HP:0002984) | 2.05804503 |
| 114 | Reduced antithrombin III activity (HP:0001976) | 2.05232229 |
| 115 | Nasolacrimal duct obstruction (HP:0000579) | 2.03802286 |
| 116 | Meningitis (HP:0001287) | 2.03239051 |
| 117 | Paralysis (HP:0003470) | 2.02582093 |
| 118 | Lipoatrophy (HP:0100578) | 2.02425239 |
| 119 | Rhinitis (HP:0012384) | 2.02054817 |
| 120 | Alacrima (HP:0000522) | 2.01253779 |
| 121 | Muscular dystrophy (HP:0003560) | 2.01049866 |
| 122 | Hyperkalemia (HP:0002153) | 1.99213387 |
| 123 | Craniofacial hyperostosis (HP:0004493) | 1.97589834 |
| 124 | Abnormality of the foot musculature (HP:0001436) | 1.97056676 |
| 125 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.96779923 |
| 126 | Lower limb amyotrophy (HP:0007210) | 1.96354059 |
| 127 | Pallor (HP:0000980) | 1.96013264 |
| 128 | Renal agenesis (HP:0000104) | 1.93598814 |
| 129 | Abnormal number of erythroid precursors (HP:0012131) | 1.92708094 |
| 130 | Submucous cleft hard palate (HP:0000176) | 1.92149670 |
| 131 | Hypophosphatemic rickets (HP:0004912) | 1.92023510 |
| 132 | Round ear (HP:0100830) | 1.91539560 |
| 133 | Hypoplasia of the ulna (HP:0003022) | 1.86603916 |
| 134 | Exercise intolerance (HP:0003546) | 1.86062747 |
| 135 | Seborrheic dermatitis (HP:0001051) | 1.85778060 |
| 136 | Foot dorsiflexor weakness (HP:0009027) | 1.85581841 |
| 137 | Popliteal pterygium (HP:0009756) | 1.85013983 |
| 138 | Amelogenesis imperfecta (HP:0000705) | 1.85013933 |
| 139 | Abnormally folded helix (HP:0008544) | 1.84752016 |
| 140 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.84176380 |
| 141 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.82583663 |
| 142 | Abnormality of magnesium homeostasis (HP:0004921) | 1.82092585 |
| 143 | Esotropia (HP:0000565) | 1.81879145 |
| 144 | Chin dimple (HP:0010751) | 1.81674034 |
| 145 | Partial duplication of thumb phalanx (HP:0009944) | 1.80151920 |
| 146 | Fibular aplasia (HP:0002990) | 1.79011383 |
| 147 | Increased hepatocellular lipid droplets (HP:0006565) | 1.78428959 |
| 148 | Proximal amyotrophy (HP:0007126) | 1.78335540 |
| 149 | Asplenia (HP:0001746) | 1.77989754 |
| 150 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.77985089 |
| 151 | Partial duplication of the phalanx of hand (HP:0009999) | 1.77157958 |
| 152 | Peripheral hypomyelination (HP:0007182) | 1.77039866 |
| 153 | Hypothermia (HP:0002045) | 1.76127074 |
| 154 | Severe visual impairment (HP:0001141) | 1.76004447 |
| 155 | Decreased lacrimation (HP:0000633) | 1.75233321 |
| 156 | Morphological abnormality of the middle ear (HP:0008609) | 1.74888064 |
| 157 | Abnormality of the pulmonary veins (HP:0011718) | 1.73394693 |
| 158 | Pulmonary artery stenosis (HP:0004415) | 1.72073078 |
| 159 | Neonatal respiratory distress (HP:0002643) | 1.72055335 |
| 160 | Hypertensive crisis (HP:0100735) | 1.71989390 |
| 161 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.71891637 |
| 162 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.71891637 |
| 163 | Pelvic girdle muscle weakness (HP:0003749) | 1.71409594 |
| 164 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.70914294 |
| 165 | Absent speech (HP:0001344) | 1.70714406 |
| 166 | Facial diplegia (HP:0001349) | 1.68832084 |
| 167 | Limb-girdle muscle weakness (HP:0003325) | 1.67203287 |
| 168 | Shoulder girdle muscle weakness (HP:0003547) | 1.66447291 |
| 169 | Stage 5 chronic kidney disease (HP:0003774) | 1.66373036 |
| 170 | Anomalous pulmonary venous return (HP:0010772) | 1.65565752 |
| 171 | Metatarsus adductus (HP:0001840) | 1.65381905 |
| 172 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.65241658 |
| 173 | Recurrent cutaneous fungal infections (HP:0011370) | 1.64564028 |
| 174 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.64564028 |
| 175 | Focal motor seizures (HP:0011153) | 1.64140234 |
| 176 | Heart block (HP:0012722) | 1.63254193 |
| 177 | Increased intramyocellular lipid droplets (HP:0012240) | 1.62492335 |
| 178 | Abnormal atrioventricular conduction (HP:0005150) | 1.58964305 |
| 179 | Increased muscle lipid content (HP:0009058) | 1.55203515 |
| 180 | Muscle fiber atrophy (HP:0100295) | 1.54611251 |
| 181 | Type 2 muscle fiber atrophy (HP:0003554) | 1.53616379 |
| 182 | Ulnar deviation of finger (HP:0009465) | 1.53607020 |
| 183 | Easy fatigability (HP:0003388) | 1.50706630 |
| 184 | Achilles tendon contracture (HP:0001771) | 1.49945718 |
| 185 | Ventricular arrhythmia (HP:0004308) | 1.49797185 |
| 186 | Congenital hip dislocation (HP:0001374) | 1.48494634 |
| 187 | Long clavicles (HP:0000890) | 1.46127564 |
| 188 | Generalized amyotrophy (HP:0003700) | 1.40739303 |
| 189 | Stridor (HP:0010307) | 1.40374183 |
| 190 | Fatigue (HP:0012378) | 1.31219134 |
| 191 | Abnormality of the Achilles tendon (HP:0005109) | 1.30205054 |
| 192 | Limited hip movement (HP:0008800) | 1.29435803 |
| 193 | Short palpebral fissure (HP:0012745) | 1.28881097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 7.25053394 |
| 2 | TTN | 6.35087922 |
| 3 | MKNK2 | 5.76438370 |
| 4 | BLK | 3.93573336 |
| 5 | TNIK | 3.68881976 |
| 6 | MKNK1 | 3.34922656 |
| 7 | TLK1 | 3.01796547 |
| 8 | MAP2K3 | 2.70514677 |
| 9 | PHKG2 | 2.45382983 |
| 10 | PHKG1 | 2.45382983 |
| 11 | FES | 2.33746516 |
| 12 | MUSK | 2.19746817 |
| 13 | MAPK12 | 2.07269232 |
| 14 | STK16 | 1.94157611 |
| 15 | NLK | 1.89815666 |
| 16 | IRAK3 | 1.83728430 |
| 17 | IRAK4 | 1.82605875 |
| 18 | IRAK1 | 1.69902305 |
| 19 | NME2 | 1.65410796 |
| 20 | CLK1 | 1.62904224 |
| 21 | IRAK2 | 1.61082444 |
| 22 | MAP3K7 | 1.58237320 |
| 23 | PINK1 | 1.48322104 |
| 24 | PRKD2 | 1.31601731 |
| 25 | MAPKAPK3 | 1.30441146 |
| 26 | PKN1 | 1.29117243 |
| 27 | YES1 | 1.28385396 |
| 28 | PRPF4B | 1.27141184 |
| 29 | TNK2 | 1.21438176 |
| 30 | MOS | 1.19586232 |
| 31 | MAP2K4 | 1.14409944 |
| 32 | MAPK15 | 1.12276632 |
| 33 | TRPM7 | 1.09791964 |
| 34 | PIK3CG | 1.06170602 |
| 35 | MAP3K13 | 1.05255256 |
| 36 | EEF2K | 1.05069193 |
| 37 | EIF2AK2 | 1.02572034 |
| 38 | STK39 | 0.99988387 |
| 39 | TAOK2 | 0.98974259 |
| 40 | TRIB3 | 0.98417063 |
| 41 | CDK19 | 0.95921764 |
| 42 | MAP3K14 | 0.95690763 |
| 43 | CSK | 0.94598609 |
| 44 | PIM2 | 0.94589478 |
| 45 | FGR | 0.92949105 |
| 46 | LIMK1 | 0.91609642 |
| 47 | PAK2 | 0.91071179 |
| 48 | OBSCN | 0.88131412 |
| 49 | FER | 0.87942177 |
| 50 | MAP2K6 | 0.85857204 |
| 51 | DYRK1B | 0.85612232 |
| 52 | SRPK1 | 0.84482835 |
| 53 | KSR2 | 0.83059585 |
| 54 | ERN1 | 0.80876835 |
| 55 | GRK7 | 0.80296685 |
| 56 | MST4 | 0.77616144 |
| 57 | MAPK7 | 0.77551622 |
| 58 | ICK | 0.76556537 |
| 59 | BMPR1B | 0.76332234 |
| 60 | PBK | 0.75204551 |
| 61 | PRKAA2 | 0.74784930 |
| 62 | CCNB1 | 0.74704604 |
| 63 | BCKDK | 0.73807293 |
| 64 | NEK1 | 0.72923283 |
| 65 | RIPK1 | 0.71801774 |
| 66 | GRK1 | 0.71175643 |
| 67 | MAP3K11 | 0.69743306 |
| 68 | ADRBK2 | 0.68672198 |
| 69 | ARAF | 0.67677539 |
| 70 | DYRK1A | 0.67109065 |
| 71 | TAOK3 | 0.66260659 |
| 72 | CDK3 | 0.65553278 |
| 73 | KIT | 0.64266726 |
| 74 | TXK | 0.63933028 |
| 75 | IKBKE | 0.63880713 |
| 76 | OXSR1 | 0.62280950 |
| 77 | CAMK2B | 0.60856163 |
| 78 | RPS6KA5 | 0.60412017 |
| 79 | NME1 | 0.59981881 |
| 80 | MAPK11 | 0.59314436 |
| 81 | TEC | 0.59230660 |
| 82 | PDK2 | 0.58196624 |
| 83 | EPHB1 | 0.57983864 |
| 84 | SIK1 | 0.57128402 |
| 85 | MAP2K2 | 0.54842142 |
| 86 | DYRK2 | 0.54824688 |
| 87 | RIPK4 | 0.54315847 |
| 88 | MAP3K3 | 0.53706599 |
| 89 | PRKG1 | 0.53383392 |
| 90 | CSNK1G1 | 0.53018275 |
| 91 | ZAP70 | 0.52471018 |
| 92 | AKT2 | 0.52112473 |
| 93 | CAMK4 | 0.51944279 |
| 94 | HIPK2 | 0.51860753 |
| 95 | PAK1 | 0.51055457 |
| 96 | INSRR | 0.50994725 |
| 97 | PRKAA1 | 0.50828322 |
| 98 | NEK9 | 0.50058615 |
| 99 | MAPKAPK5 | 0.48932925 |
| 100 | UHMK1 | 0.47693552 |
| 101 | LYN | 0.45513705 |
| 102 | SGK3 | 0.45466129 |
| 103 | MAPK13 | 0.45056862 |
| 104 | IKBKB | 0.44855097 |
| 105 | HCK | 0.44013784 |
| 106 | VRK1 | 0.43688016 |
| 107 | LCK | 0.43667502 |
| 108 | EIF2AK3 | 0.43186259 |
| 109 | BRAF | 0.42255934 |
| 110 | MAP2K1 | 0.41975581 |
| 111 | CAMK1 | 0.41495993 |
| 112 | TYK2 | 0.40493931 |
| 113 | PNCK | 0.39428028 |
| 114 | NEK6 | 0.39148884 |
| 115 | CAMK2A | 0.38875211 |
| 116 | DMPK | 0.38712516 |
| 117 | TAOK1 | 0.38575785 |
| 118 | BMX | 0.36016479 |
| 119 | MAP3K1 | 0.35863600 |
| 120 | TIE1 | 0.35376264 |
| 121 | PDPK1 | 0.35198348 |
| 122 | EPHB2 | 0.35028745 |
| 123 | DYRK3 | 0.31908814 |
| 124 | RAF1 | 0.30873720 |
| 125 | STK11 | 0.30731680 |
| 126 | CAMK2D | 0.30601033 |
| 127 | CAMK2G | 0.30565719 |
| 128 | BMPR2 | 0.30109761 |
| 129 | RPS6KC1 | 0.29661759 |
| 130 | RPS6KL1 | 0.29661759 |
| 131 | MARK2 | 0.29139699 |
| 132 | SIK2 | 0.29015320 |
| 133 | PRKD1 | 0.28594042 |
| 134 | ROCK1 | 0.27961253 |
| 135 | ROCK2 | 0.27397219 |
| 136 | GSK3A | 0.26830684 |
| 137 | TGFBR2 | 0.26784606 |
| 138 | BTK | 0.26635744 |
| 139 | MAPK4 | 0.25610260 |
| 140 | TBK1 | 0.25551154 |
| 141 | PRKCQ | 0.25538253 |
| 142 | MARK1 | 0.25415311 |
| 143 | MARK3 | 0.23786760 |
| 144 | ABL1 | 0.23728150 |
| 145 | CDC42BPA | 0.23704079 |
| 146 | MAP2K7 | 0.22904349 |
| 147 | LATS2 | 0.20755205 |
| 148 | PDK1 | 0.20561586 |
| 149 | CSNK1A1L | 0.20430283 |
| 150 | RPS6KA6 | 0.20169278 |
| 151 | CSNK1D | 0.20098473 |
| 152 | NUAK1 | 0.19825199 |
| 153 | ERBB3 | 0.19656682 |
| 154 | SGK2 | 0.19028451 |
| 155 | RPS6KA1 | 0.18936087 |
| 156 | MAP3K6 | 0.17258702 |
| 157 | PRKG2 | 0.16738550 |
| 158 | MAPK10 | 0.16618874 |
| 159 | PRKACA | 0.16301171 |
| 160 | MTOR | 0.16259030 |
| 161 | SYK | 0.15796262 |
| 162 | RPS6KA2 | 0.15481657 |
| 163 | KSR1 | 0.15090934 |
| 164 | ABL2 | 0.14626678 |
| 165 | SGK1 | 0.13101227 |
| 166 | MAP3K8 | 0.12045175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.05674160 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.83533034 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.77556226 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.53944950 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.45204064 |
| 6 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.71538642 |
| 7 | Carbon metabolism_Homo sapiens_hsa01200 | 2.42488220 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 2.41472483 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.30521374 |
| 10 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.30342467 |
| 11 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.21290887 |
| 12 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.14365580 |
| 13 | Circadian rhythm_Homo sapiens_hsa04710 | 2.10145858 |
| 14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.10043375 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.03588547 |
| 16 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.91816173 |
| 17 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.90801016 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.86840365 |
| 19 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.83294638 |
| 20 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.80064557 |
| 21 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.77410301 |
| 22 | Insulin resistance_Homo sapiens_hsa04931 | 1.72510896 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.71948443 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.71274025 |
| 25 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.60544312 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.58082411 |
| 27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.54873939 |
| 28 | Homologous recombination_Homo sapiens_hsa03440 | 1.53878639 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.53626701 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.52192768 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.50766675 |
| 32 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.50730199 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47976249 |
| 34 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.47755109 |
| 35 | Axon guidance_Homo sapiens_hsa04360 | 1.46659862 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.46457250 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.45597194 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43178875 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.37813077 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.36786043 |
| 41 | Nicotine addiction_Homo sapiens_hsa05033 | 1.34463711 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.33647069 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.33553214 |
| 44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.33127055 |
| 45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.32752129 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29079880 |
| 47 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.27971416 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25563243 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 1.25457069 |
| 50 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.24304832 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 1.24224196 |
| 52 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.18866034 |
| 53 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.16627942 |
| 54 | Spliceosome_Homo sapiens_hsa03040 | 1.11158968 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.09307835 |
| 56 | RNA polymerase_Homo sapiens_hsa03020 | 1.08988929 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08291298 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.98818882 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97974331 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97160796 |
| 61 | Leishmaniasis_Homo sapiens_hsa05140 | 0.96222185 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.95470247 |
| 63 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.95233473 |
| 64 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.94922665 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94640611 |
| 66 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.91029934 |
| 67 | Taste transduction_Homo sapiens_hsa04742 | 0.89779001 |
| 68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.85522536 |
| 69 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.85459309 |
| 70 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.84750675 |
| 71 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.82402731 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.82131061 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.82113425 |
| 74 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82063003 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80954714 |
| 76 | Measles_Homo sapiens_hsa05162 | 0.80553883 |
| 77 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.79075759 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77641737 |
| 79 | Basal transcription factors_Homo sapiens_hsa03022 | 0.77390299 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76558152 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75659209 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.74130333 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.73963178 |
| 84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73180026 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.73060380 |
| 86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72839148 |
| 87 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.72770933 |
| 88 | Melanoma_Homo sapiens_hsa05218 | 0.69970826 |
| 89 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.69464669 |
| 90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68629422 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.68535892 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67490086 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.67251322 |
| 94 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67203190 |
| 95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.66589763 |
| 96 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.65735064 |
| 97 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.65162822 |
| 98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.63667316 |
| 99 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.63407706 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62882040 |
| 101 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.62270358 |
| 102 | Morphine addiction_Homo sapiens_hsa05032 | 0.62022390 |
| 103 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.61267240 |
| 104 | Huntingtons disease_Homo sapiens_hsa05016 | 0.61139649 |
| 105 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60241392 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59836974 |
| 107 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.59818660 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59782559 |
| 109 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59568479 |
| 110 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.59280244 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59260923 |
| 112 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59121162 |
| 113 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58995015 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58032040 |
| 115 | Prostate cancer_Homo sapiens_hsa05215 | 0.57780683 |
| 116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56936568 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56883471 |
| 118 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56867396 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56349454 |
| 120 | Amoebiasis_Homo sapiens_hsa05146 | 0.56088288 |
| 121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55366353 |
| 122 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54904962 |
| 123 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.52751333 |
| 124 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52664778 |
| 125 | Parkinsons disease_Homo sapiens_hsa05012 | 0.52512700 |
| 126 | Tight junction_Homo sapiens_hsa04530 | 0.51628956 |
| 127 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51394817 |
| 128 | Phagosome_Homo sapiens_hsa04145 | 0.50721349 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49589784 |
| 130 | Salivary secretion_Homo sapiens_hsa04970 | 0.48956500 |
| 131 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48465637 |
| 132 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.47907907 |
| 133 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.47722129 |
| 134 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46670975 |
| 135 | Purine metabolism_Homo sapiens_hsa00230 | 0.46650446 |
| 136 | Bladder cancer_Homo sapiens_hsa05219 | 0.46606832 |
| 137 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.46162866 |
| 138 | Salmonella infection_Homo sapiens_hsa05132 | 0.45643039 |
| 139 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45621556 |
| 140 | DNA replication_Homo sapiens_hsa03030 | 0.45543863 |
| 141 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45481326 |
| 142 | Platelet activation_Homo sapiens_hsa04611 | 0.44778592 |
| 143 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.44627457 |
| 144 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44498100 |
| 145 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44466180 |
| 146 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44378394 |
| 147 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43977742 |
| 148 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43781022 |
| 149 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43545446 |
| 150 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42861239 |
| 151 | Tuberculosis_Homo sapiens_hsa05152 | 0.42812080 |
| 152 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42672030 |
| 153 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42195457 |
| 154 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.38004381 |
| 155 | Renin secretion_Homo sapiens_hsa04924 | 0.34157646 |
| 156 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34030125 |
| 157 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31446928 |
| 158 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31093700 |
| 159 | Glioma_Homo sapiens_hsa05214 | 0.30420188 |
| 160 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.30306001 |
| 161 | Legionellosis_Homo sapiens_hsa05134 | 0.27392919 |
| 162 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.23230137 |
| 163 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22847760 |
| 164 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22583362 |
| 165 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.20100207 |
| 166 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.17616673 |
| 167 | Endometrial cancer_Homo sapiens_hsa05213 | 0.12946677 |
| 168 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.12070027 |
| 169 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.12061300 |
| 170 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09889996 |

